Vanguard AG
  • Devices
    • Medical Remanufacturing
    • Catalogue
    • Electrophysiology
      • CARTO3
      • EnSite Precision
    • Surgical Instruments
      • Harmonic
    • Purchase of used medical devices
    • eIFU
  • About us
    • Sustainability
    • Economy
    • Safety
    • AMDR
  • Career
  • News
  • Downloads
    • eIFU
  • Contact
  • LogIn
  • English
    • Deutsch
    • English
    • Español
    • Nederlands
    • Français
Select Page
Hygienic, safe, compliant: CE, CS and KRINKO in remanufacturing practice

Hygienic, safe, compliant: CE, CS and KRINKO in remanufacturing practice

by Clemens Köhler | 11. March 2026 | News (en)

CE remanufacturing: remanufacturing with manufacturer responsibility In CE remanufacturing, the medical device originally labelled as single-use becomes the property of Vanguard and is subsequently restored through a validated remanufacturing process. In accordance...
TÜV NORD Awards First MDR Certificate for CE Reprocessing to Vanguard AG

TÜV NORD Awards First MDR Certificate for CE Reprocessing to Vanguard AG

by MarketingVanguard | 23. February 2026 | News (en)

CE reprocessing of single-use devices means that Vanguard assumes full responsibility as a medical device manufacturer under the MDR. This includes technical documentation, clinical evaluation, post-market surveillance and vigilance. The certification process was...
Agroforestry Project Update: A Diverse Ecosystem Is Taking Shape on Field 701

Agroforestry Project Update: A Diverse Ecosystem Is Taking Shape on Field 701

by Clemens Köhler | 11. February 2026 | News (en)

A total of 36 woody vegetation strips have been established across the arable field. These are divided into three row types: sweet chestnut, fodder trees and standard fruit trees. Within these strips, 55 different woody and herbaceous species have been introduced,...
Why We Need to Talk About “Scope 4” and the Contribution Remanufacturing Can Make

Why We Need to Talk About “Scope 4” and the Contribution Remanufacturing Can Make

by Clemens Köhler | 27. January 2026 | News (en)

A Missing Element in the Emissions Framework: The Concept of Scope 4 Scope 4 describes exactly what is missing from the current system: the avoidance of emissions through reuse, repair, or remanufacturing. While Scopes 1–3 measure what companies generate, Scope 4...
ISO 13485 – Quality management as one of the prerequisites for safe medical devices

ISO 13485 – Quality management as one of the prerequisites for safe medical devices

by Clemens Köhler | 13. January 2026 | News (en)

Why manufacturers of medical devices cannot do without this standard ISO 13485 is the internationally recognized standard that defines the requirements for a comprehensive quality management system (QMS) for the design, development and manufacture of medical devices,...
Circular Economy in Medical Technology: Taking Responsibility, Securing the Future – Ulrike Marczak in Conversation with abfallmanager-medizin.de

Circular Economy in Medical Technology: Taking Responsibility, Securing the Future – Ulrike Marczak in Conversation with abfallmanager-medizin.de

by Clemens Köhler | 7. January 2026 | News (en)

“Healthcare is a system-relevant sector, while at the same time having a significant impact on environmental pollution. […] More than 70 percent of emissions in this sector are caused by the production and supply chains of medical devices. It therefore makes perfect...
« Older Entries

Recent Posts

  • Hygienic, safe, compliant: CE, CS and KRINKO in remanufacturing practice
  • TÜV NORD Awards First MDR Certificate for CE Reprocessing to Vanguard AG
  • Agroforestry Project Update: A Diverse Ecosystem Is Taking Shape on Field 701
  • Why We Need to Talk About “Scope 4” and the Contribution Remanufacturing Can Make
  • ISO 13485 – Quality management as one of the prerequisites for safe medical devices

Recent Comments

No comments to show.

Vanguard AG
Landsberger Str. 222
12623 Berlin
Deutschland
Kundenservice: 030 - 318 73 43 - 300

Vanguard Medical Devices Limited
The Scalpel, 18th Floor, 52 Lime Street
London EC3M 7AF
UK

International customer service:
+49 30 - 318 73 43 - 300

© 2026 Vanguard AG. All rights reserved.

Impressum   Datenschutzerklärung   AGB   Kontakt   Datenschutzhinweise für Aktionäre